Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine

Inclusion Criteria

• •To be eligible to participate in this study, all of the following criteria must be met:
• •Male and female ambulatory patients with Parkinson's disease diagnosis (as per the London Brain Bank diagnosis criteria) ≥6 months ago
• •Patient aged 30 years or older at the time of Parkinson's disease diagnosis
• •Patients who were under treatment with Rotigotine following routine clinical practice, either alone or in combination with Levodopa, and in an advanced PD dosage (≥ 8 mg/ 24 h) for at least the previous 6 months
• •Patients under treatment with Rotigotine (≥ 8 mg/ 24 h) who were assessed twice of NMS by means of the PDNMS-Q 6 months apart
• •Patients are currently informed and have been given enough time and opportunity to think about participation (data collection) in the study and have given written informed consent